Peredo Aguilar, M. A. (2023). Part A - PD-1/PD-L1 blockade in cancer immunotherapy/ Part B - Evaluation of PD-1/PD-L1 immune checkpoint inhibitors in a luciferase-reporter cell-based assay.
Chicago Style (17th ed.) CitationPeredo Aguilar, Maria Azucena. Part A - PD-1/PD-L1 Blockade in Cancer Immunotherapy/ Part B - Evaluation of PD-1/PD-L1 Immune Checkpoint Inhibitors in a Luciferase-reporter Cell-based Assay. 2023.
MLA (9th ed.) CitationPeredo Aguilar, Maria Azucena. Part A - PD-1/PD-L1 Blockade in Cancer Immunotherapy/ Part B - Evaluation of PD-1/PD-L1 Immune Checkpoint Inhibitors in a Luciferase-reporter Cell-based Assay. 2023.
Warning: These citations may not always be 100% accurate.